The second wave of the deadly coronavirus is slowly gripping the United States. On Wednesday, the nation recorded over 100,000 COVID-19 cases in a single day, a new record. Maine, Indiana, Minnesota, Nebraska, and Colorado are the worst impacted states. The rise in death toll by 21% across the country is even more disturbing. Experts say that as winter is approaching, there is dual risk from the pandemic as well as the virulent flu.
At this juncture, investors need to take a hard look at their portfolio. To maximize gains, they must pick stocks which have the ability to capitalize on the looming crisis. The businesses of these stocks should be in a position to flourish as the intensity of COVID-19 increases. Companies which can identify opportunities in the crisis and position themselves for gains will survive in the long run.
As the pandemic rolls on, we will need a high quality and agile healthcare system. Moreover, as we spend more time indoors, the companies that make life simpler for us through offerings will also be in demand. Evidently, the companies primarily involved in vaccine development and virtual healthcare will be some of the biggest beneficiaries. Similarly, technology companies that enable a seamless remote working environment have gained immensely during this phase and should continue to do so.
Johnson & Johnson (JNJ), Zoom Video Communications, Inc. (ZM), Teladoc Health, Inc. (TDOC), and Quidel Corporation (QDEL) are four such companies that are poised to soar further as the COVID-19 crisis deepens.
Johnson & Johnson (JNJ)
JNJ is known for its consumer products such as baby care, womens health, and wound-care. However, it has a major presence in the pharmaceutical and the medical devices segments as well. JNJs pharmaceutical segment focusses on immunology, pulmonary hypertension, neuroscience, infectious diseases, oncology, and cardiovascular diseases. Meanwhile, the companys medical segment deals with surgical, orthopedic, cardiovascular, diabetes care, and ophthalmic requirements.
Earlier this month, JNJ entered into a preliminary agreement with South African pharmaceutical giant, Aspen Pharmacare Holdings, to manufacture 300 million doses/year of the COVID-19 vaccine candidate, Ad26.COV2-S, commercially. The objective behind this association is to distribute the vaccine in the South African continent, which has limited manufacturing capacity.
JNJ rebounded in the third quarter that ended September 2020. The companys revenue for the quarter climbed 1.7% to $21 billion. The consumer products segment saw a recovery in revenue, but the medical devices segment declined 3.6%. Notably, JNJs pharmaceutical segment could withstand the adverse market condition, driven by the robust momentum of its blockbuster drugs, Darzalex, Stelara, Zytiga, and Imbruvica. JNJs EPS for the third quarter surged 101.5% year-over-year to $1.33.
The street estimates JNJs fourth-quarter revenue to be $21.7 billion, indicating a 4.7% rise year-over-year. Meanwhile, EPS for the quarter is likely to drop 2.7% to $1.83. Over the past year, JNJ gained 7% to close yesterdays session at $139.76.
How does JNJ stack up for thePOWR Ratings?
B for Buy & Hold Grade
A for Peer Grade
B for Industry Rank
B for Overall POWR Rating
The stock is also ranked #6 out of 240 stocks in the Medical Pharmaceuticalsindustry.
Zoom Video Communications, Inc. (ZM)
ZM is one of the leading unified communication platforms. It offers video and online chat services, enabled by a cloud-based peer-to-peer software platform. Some of the other services include telecommuting, social chats, online education, and webinars. Over $100,000 of ZMs trailing 12-month revenue is contributed by more than 900 customers. The company has become the most preferred platform for people working and studying remotely in this pandemic. Soon, the company intends to enter the online event hosting segment.
According to a recent development, German telecom giant, Deutsche Telekom, entered into a sales partnership withZM. This implies that the market share of ZM will expand into Germany as more users are likely to sign up for the videoconferencing services through the nations leading telecom operator.
During the second quarter that ended June 2020, ZMs total revenue jumped 355% year-over-year to $663.5 million. EPS for the quarter tripled to $0.63. At the end of the second quarter, the company had nearly 370,200 customers, indicating a growth of 458% from the year-ago period.
ZMs third-quarter revenue is expected to be $639.35 million, indicating a 316.2% increase year-over-year. Meanwhile, the street estimates EPS for the quarter to surge 744.4% to $0.76. ZM expects its revenue for the third quarter that ended September to be in the range of $685.0 millionto$690.0 million.
On a year-to-date basis, ZM rallied 630% to close yesterdays session at $496.73. During the past six months, ZM has soared 243%. A second wave of COVID-19 is likely to push people to stay indoors. As a result, there will be increased dependence on ZM for remote working and online education.
ZMs POWR Ratings reflect its promising outlook. It has an overall rating of Buy with a B in Trade Grade and Peer Grade. The stock is also ranked #5 out of 54 stocks in the Technology Servicesindustry.
Teladoc Health, Inc. (TDOC)
TDOC is a leading provider of telehealthcare. The company offers its services through technology platforms like mobile devices, internet, phone, laptop, etc. This virtual healthcare company deals with a wide array of medical conditions like episodic flu and chronic infections to complex diseases like cancer and congestive heart failure. TDOC also includes AI and analytics to its medical offerings. Since the beginning of this year, TDOC has logged in three million extra enabled visits for its health system clients.
On October 30th, TDOC completed its merger with Livongo (LVGO), a renowned Applied Health Signals company. According to experts, this collaboration would transform the companys position as the topmost customer-centric healthcare company in the world. CEO of TDOC, Jason Gorevic, said, Together, our team will achieve the full promise of whole-person virtual care, leveraging our combined applied analytics, expert guidance and connected technology to deliver, enable and empower better health outcomes..
The companys revenue for the third quarter that ended September 2020, soared 109% year-over-year to $288.8 million. Total visits to its platform also jumped 206% to 2.8 million for the quarter. However, TDOCs loss per share widened to $0.43 from $0.28 posted in the same period last year.
Analysts estimate the revenue for the fourth quarter ending December to be $306.3 million, indicating a 95.7% increase year-over-year. The loss per share is expected to narrow to $0.38 for the fourth quarter. The company also boosted its guidance for full year revenue to $546-$550 million, from the previous forecast of $538-$545 million. TDOC expects to directly deliver over 10 million virtual visits in 2020.
TDOC rallied 137.4% on a year-to-date basis to end yesterdays session at $208.51, driven by rising demand for virtual healthcare services amid the pandemic. The stock surged 14% over the past six months.
Under our POWR Ratings system, TDOC has been accorded a B grade in Trade Grade, and Industry Rank. Among the 70 stocks in the Medical Servicesindustry, its ranked #26.
Quidel Corporation (QDEL)
QDEL is a leading developer, manufacturer, and seller of diagnostic testing solutions for various diseases such as cardiology, thyroid, eye health, gastrointestinal, and toxicology. QDEL also focuses on womens and general healthcare. Two fluorescent immunoassay systems offered by the company are Sofia and Sofia 2. AdenoPlus, another brand manufactured by QDEL, includes point-of-care products for detecting infectious and inflammatory diseases as well as eye conditions.
QDEL has developed the first FDA-authorized ABC rapid antigen test which can detect and differentiate between Influenza A + B and COVID-19 through a single nasal swab in just 15 minutes.
During the third quarter that ended September 2020, QDELs revenue surged 276% year-over-year to $476.1 million, led by the growth in Rapid Immunoassay and Molecular Diagnostic Solutions. Nearly 80% of the sales were contributed by COVID-19 products. QDELs newly launched Sofia SARS Antigen and Lyra SARS-CoV-2 tests saw huge demand. The companys EPS for the third quarter climbed 725.7% to $5.33.
Analysts expect revenue for the fourth quarter ending December to be $757.9 million, indicating an increase of 398.1% year-over-year. Meanwhile, the EPS is expected to surge 819% to $9.19.
On a year-to-date basis, QDEL has rallied 257.6% to close yesterdays session at $281.80. Over the past six months, the stock has soared 93%. The companys increased focus on developing rapid testing kits for COVID-19 has led its stock to skyrocket this year.
Its no surprise that QDEL is rateda Buy in our POWR Ratings system. It also has an A for Trade Grade, and a B for Buy & Hold Grade, Peer Grade, and Industry Rank. In the 58-stockMedical-Diagnostics/Researchindustry, it is ranked #10.
Want More Great Investing Ideas?
Stocks Face SOARING Risk in November?
7 Best ETFs for theNEXTBull Market
5 WINNING Stocks Chart Patterns
JNJ shares were trading at $142.49 per share on Friday afternoon, up $2.73 (+1.95%). Year-to-date, JNJ has declined -0.35%, versus a 10.34% rise in the benchmark S&P 500 index during the same period.
More here:
JNJ: 4 Coronavirus Stocks to Buy for the Second Wave - StockNews.com
- Molecular Cardiology Research Lab - Texas Heart Institute - April 15th, 2018 [April 15th, 2018]
- Cardiology - Cardiologists - New York - Montefiore Medical ... - May 7th, 2018 [May 7th, 2018]
- PET/CT - Molecular Imaging - Nuclear MedicinePET-CTPET ... - May 26th, 2018 [May 26th, 2018]
- Molecular Cardiology Centenary Institute - July 16th, 2018 [July 16th, 2018]
- Pediatric Cardiology Fellowship | Pediatrics | University ... - September 25th, 2018 [September 25th, 2018]
- Molecular Multi - 3formulas.com - November 4th, 2018 [November 4th, 2018]
- Society of Nuclear Medicine and Molecular Imaging (SNMMI) - December 20th, 2018 [December 20th, 2018]
- Cardiology 2019 | Cardiology Conferences | Cardiology ... - February 5th, 2019 [February 5th, 2019]
- Cardiology | medicine | Britannica.com - March 18th, 2019 [March 18th, 2019]
- Cardiology | Baylor College of Medicine | Houston, Texas - April 12th, 2019 [April 12th, 2019]
- Cardiology Conferences | Cardiology Meetings | cardiology ... - September 11th, 2019 [September 11th, 2019]
- Nuclear Medicine/Radiopharmaceuticals Market Research Report by Key Players Analysis - Rapid News Network - September 21st, 2019 [September 21st, 2019]
- Macroscopic Imaging Market Growth with Worldwide Industry Analysis to 2019-2027 - Rapid News Network - September 21st, 2019 [September 21st, 2019]
- PET MRI Market to Record an Exponential CAGR by 2025 - Analytics News - September 21st, 2019 [September 21st, 2019]
- In Vitro Diagnostics/IVD Market Rapid Growth with Rising Application Scope by 2026 | Top Players- Danaher, Abbott, Thermo Fisher Scientific Inc,... - September 21st, 2019 [September 21st, 2019]
- Nuclear Imaging Devices Market Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecast - Wolf Mirror - September 21st, 2019 [September 21st, 2019]
- Heparin-induced Thrombocypenia Treatment Market Size & Share Expanding Across The Globe By 2018 2028 - NewsVarsity - September 21st, 2019 [September 21st, 2019]
- Medical Animation Market is Booming at a CAGR of 8.5% Due To Growing Demand By 2019 - 2026 - US Trade Media - September 21st, 2019 [September 21st, 2019]
- Molecular Imaging Market Will Make a Huge Impact in Near Future - Wolf Mirror - September 21st, 2019 [September 21st, 2019]
- FDA Clears ARTIS icono Family of Angiography Systems From Siemens Healthineers - BioSpace - September 21st, 2019 [September 21st, 2019]
- MR Solutions' liquid helium free PET-MR system firmly on the agenda at WMIC - DOTmed HealthCare Business News - September 21st, 2019 [September 21st, 2019]
- Molecular Imaging Devices Market Forecast to 2024 Explored in Latest Research - OnYourDesks - September 21st, 2019 [September 21st, 2019]
- Antibody Production Market Overview on Key Innovations 2023 - TodayTimes - September 24th, 2019 [September 24th, 2019]
- BRIC IVD Market Overview and Scope 2019 to 2024 | Key Players: Roche Diagnostics, Abbott Laboratories, Inc., & more Analytics News - Analytics... - September 24th, 2019 [September 24th, 2019]
- Best Report on Diagnostic Catheter Market 2026 with Major Eminent Key Players Biosense Webster, Inc, Medtronic plc, St. Jude Medical, Boston... - September 24th, 2019 [September 24th, 2019]
- Molecular Imaging Devices Market Industry Shares Report Analysis 2019-2027 - QbnNews - September 24th, 2019 [September 24th, 2019]
- Molecular Imaging Market value projected to expand by 2017 2027 - Analytics News - September 24th, 2019 [September 24th, 2019]
- ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the... - September 24th, 2019 [September 24th, 2019]
- Not for the faint-hearted: why some kids blackout playing video games - The Age - September 24th, 2019 [September 24th, 2019]
- Role of Machine Learning and AI in Precision Medicine - Healthcare Tech Outlook - October 11th, 2019 [October 11th, 2019]
- Here's Why Qiagen Plummeted Today - The Motley Fool - October 11th, 2019 [October 11th, 2019]
- Research Fellow in Muscle Biology job with UNIVERSITY OF LEEDS | 182894 - Times Higher Education (THE) - October 12th, 2019 [October 12th, 2019]
- Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Ind | DMSO - Dove Medical Press - October 17th, 2019 [October 17th, 2019]
- Contrasting of Merit Medical Systems Inc. (MMSI) and BioLife Solutions Inc. (NASDAQ:BLFS) - MS Wkly - October 18th, 2019 [October 18th, 2019]
- Unexpected Growth Seen in Radiopharmaceutical Market Global Forecast to 2025 with Key Players Bayer, Cardinal Health, GE Healthcare, ABT Molecular... - October 18th, 2019 [October 18th, 2019]
- No. 447: Thunderbolts and lasers, with Adelphi's all-world dean and the Father of Rock 'n Roll - Innovate Long Island - October 18th, 2019 [October 18th, 2019]
- Global Molecular Imaging Agents Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin - Market Research Writeup - October 22nd, 2019 [October 22nd, 2019]
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 29th, 2019 [October 29th, 2019]
- What are the Major Reasons for Rise in Molecular Imaging Market in Recent Period? - The Chicago Sentinel - October 29th, 2019 [October 29th, 2019]
- IVD Market insights size status gross margin and outlook 2019-2025 investigated in the latest research -... - WhaTech - October 30th, 2019 [October 30th, 2019]
- Radiopharmaceutical Market Size, Share 2019 - Growth Insight, Comprehensive Analysis, Top Leading Players, Future Demand and Forecast to 2023 -... - October 30th, 2019 [October 30th, 2019]
- This is the world's smallest commercially available sensor, and it really is tiny! - RedShark News - October 30th, 2019 [October 30th, 2019]
- New model of irregular heartbeat could boost drug efficacy | The Source - Washington University in St. Louis Newsroom - October 30th, 2019 [October 30th, 2019]
- Global In Vitro Diagnostics (IVD) Market Industry Analysis and Forecast (2018-2026) - Maxi Wire - November 7th, 2019 [November 7th, 2019]
- New Studies Demonstrate the Predictive Value of the Vectra Test in People Diagnosed with Rheumatoid Arthritis - GlobeNewswire - November 10th, 2019 [November 10th, 2019]
- BRIC IVD Market with Future Prospects, Key Player SWOT Analysis and Forecast To 2024 - Columnist 360 - December 2nd, 2019 [December 2nd, 2019]
- Global Molecular Imaging Agents Market: What it got next? Find out with the latest research available at 'The Market Reports' - Inquiry 24 - December 2nd, 2019 [December 2nd, 2019]
- Molecular Imaging Market to Witness CAGR of 7.5% Rise in Value Share During the Period 2017 2027 - chronicles24 - December 2nd, 2019 [December 2nd, 2019]
- Medical Imaging Equipment Market Global Industry Size, Revenue Growth Development, Business Opportunities, Future Trends, Top Key Players, Market... - December 12th, 2019 [December 12th, 2019]
- PhD Position in Molecular Medicine job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY -NTNU | 188846 - Times Higher Education (THE) - December 12th, 2019 [December 12th, 2019]
- Miss America 2020: Here's a look at the 51 beautiful women who will be competing to take home the crown - MEAWW - December 18th, 2019 [December 18th, 2019]
- Vitro Diagnostics Market: Key Players and Production Information analysis with Forecast 2022 - Downey Magazine - December 18th, 2019 [December 18th, 2019]
- Famed Medical Researcher Partners with Center for Vein Restoration Dr. Armin Foghi - PR Web - December 18th, 2019 [December 18th, 2019]
- Human fat cells tweaked to function like a pacemaker - Times of India - December 18th, 2019 [December 18th, 2019]
- Human fat cells tweaked to work like hearts pacemaker: Study - BusinessLine - December 18th, 2019 [December 18th, 2019]
- Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019 - TCTMD - December 18th, 2019 [December 18th, 2019]
- Global Nuclear Imaging Equipment Market 2019-2023 | Evolving Opportunities With Canon Inc. and Mediso Ltd. | Technavio - Business Wire - January 12th, 2020 [January 12th, 2020]
- Isothermal Nucleic Acid Amplification Technology Market Worth $3.3 Billion in 2024 - Exclusive Report by MarketsandMarkets - PRNewswire - January 16th, 2020 [January 16th, 2020]
- No one knew why some Amish children were dying suddenly. Now researchers have some answers - The Albany Herald - January 16th, 2020 [January 16th, 2020]
- Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System - Yahoo Finance - January 16th, 2020 [January 16th, 2020]
- Mount Sinai Research Finds that Heterogeneity of Liver Cancer Cells Help Explain Tumor Progression in Patients - PR Web - January 20th, 2020 [January 20th, 2020]
- Medical Imaging Equipment Market Size 2020, Trends, Industry Share, Business Opportunities and Demand Forecast to 2025 - Medical Market News - January 31st, 2020 [January 31st, 2020]
- Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications - Yahoo Finance - January 31st, 2020 [January 31st, 2020]
- 2020 In Vitro Diagnostics (IVD) Market Report- Growth, Challenges, Attractive Valuation and Top Key Players - Science of Change - February 1st, 2020 [February 1st, 2020]
- IVD Market To Inspect Growth Trends during Forecast Period 2019 to 2026 |Siemens, Danaher Corporation, Becton - Expedition 99 - February 1st, 2020 [February 1st, 2020]
- Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications - Business Wire - February 1st, 2020 [February 1st, 2020]
- PET Radiopharmaceuticals Market Report (2019-2025) | The demand for the Market will drastically increase in the Future - Chronicle 99 - February 17th, 2020 [February 17th, 2020]
- In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market With Top Countries Data Analysis and Forecast 2025 by Recent... - February 17th, 2020 [February 17th, 2020]
- North American Nuclear Medicine Market Expected to Reach USD 2.7 Billion by 2024 with a CAGR of 4.1% - ResearchAndMarkets.com - Business Wire - February 17th, 2020 [February 17th, 2020]
- Biologic And Medical Imaging Reagents Market to Make Great Impact in near Future by -2022 - Kentucky Journal 24 - February 17th, 2020 [February 17th, 2020]
- Global In Vitro Diagnostics (IVD) Industry, Forecast to 2027 - Molecular Diagnostics to Exhibit the Fastest Growth - Yahoo Finance - March 8th, 2020 [March 8th, 2020]
- GeneDx Celebrates 20 Year History as Pioneer In Genetic Sequencing and Testing - BioBuzz - March 22nd, 2020 [March 22nd, 2020]
- Contract Development and Manufacturing Organization Market worth USD 278.98 Billion by 2026; Increasing Demand for Pharmaceutical Products Will Aid... - March 24th, 2020 [March 24th, 2020]
- Outlook into the Global Hybrid Imaging Market to 2025 - by Application, Type, End Use and Region - Yahoo Finance - March 24th, 2020 [March 24th, 2020]
- Smoking cessation counseling and e-cigs may be effective for breaking the habit - Mental Daily - April 1st, 2020 [April 1st, 2020]
- How daylight saving time affects health, and why Turkey was right to abandon it - Daily Sabah - April 1st, 2020 [April 1st, 2020]
- Single-Photon Emission Computed Tomography Market by Key Players, Regions, Type and Application, Forecast to 2027 - Jewish Life News - April 1st, 2020 [April 1st, 2020]
- Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients - TCTMD - April 1st, 2020 [April 1st, 2020]
- In-Vitro Diagnostics Market 2020 | Top Business Growing Strategies, Technological Innovation and Emerging Trends of Outlook To 2028 - Publicist360 - April 10th, 2020 [April 10th, 2020]
- Abbott's Point-of-Care COVID-19 Test Delivers Results Within Minutes - The Cardiology Advisor - April 10th, 2020 [April 10th, 2020]